Clinical Trials Directory

Trials / Completed

CompletedNCT04387435

Optimization of VNS in Epileptic Patients to Induce Cardioprotection

A Feasibility Study to Evaluate the Safety and Effect of the Optimization of Vagus Nerve Stimulation in Epileptic Patients to Induce Cardioprotection

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1 (actual)
Sponsor
University of California, Los Angeles · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is a non-randomized, prospective study in patients with a diagnosis of epilepsy and previously implanted FDA approved Vagus Nerve Stimulation (VNS) devices. The goal of this clinical investigation is to evaluate the effects of adjusting vagus nerve stimulation parameters to engage cardioprotective effects.

Detailed description

Epilepsy patients are at increased risk for sudden cardiac death. Mechanisms behind this predisposition is poorly understood but parasympathetic dysfunction is heavily implicated. Vagus Nerve Stimulation (VNS) protocols currently set for seizure management are poorly optimized for cardioprotection, therefore this patient population presents a unique opportunity to assess VNS control of cardiac function, when VNS is appropriately titrated for cardiac and seizure benefit. This study will enroll 12 patients with a diagnosis of epilepsy and previously implanted FDA approved VNS devices. The study will last up to 9 weeks and the patient will undergo changes to their VNS settings during autonomic testing and cardiopulmonary testing.

Conditions

Interventions

TypeNameDescription
OTHERA change or titration in the current or frequency settings of the VNS therapy system.The study treatment involves changing the output current or frequency of the default device settings in a FDA approved device for VNS therapy. The proposed frequency changes in this study are within the FDA approved output current and frequency levels.

Timeline

Start date
2020-12-01
Primary completion
2021-07-07
Completion
2021-07-07
First posted
2020-05-13
Last updated
2025-04-06
Results posted
2024-08-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04387435. Inclusion in this directory is not an endorsement.